×

Treatment of EBV and KHSV infection

  • US 7,211,570 B2
  • Filed: 12/19/2002
  • Issued: 05/01/2007
  • Est. Priority Date: 12/20/2001
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for treating an animal infected with Epstein-Barr virus or KHSV comprising administering to said animal an effective amount of a compound or pharmaceutically acceptable salt thereof, said compound is selected from the group consisting of (2S,4S)-5-(2-furanyl)-1-[2-(hydroxymethyl)-1,3-dioxolan-4-yl]uracil, (2S,4S)-5-(5-bromo-2-furanyl)-1-[2-(hydroxymethyl)-1,3-dioxolan-4-yl]uracil, (2S,4S)-5-(2-thienyl)-1-[2-2-(hydroxymethyl)-1,3-dioxolan-4-yl]uracil and (2S,4S)-5-(5-bromthien-2-yl))-1-[2-(hydroxymethyl)-1,3-dioxolan-4-yl]uracil.

View all claims
  • 8 Assignments
Timeline View
Assignment View
    ×
    ×